Adefovir

阿德福韦

Report date: 2022/11/25 17:31:01
NME

Base Information

Drug NameAdefovir
Drug Alias NameAdefovirumPhosphonylmethoxyethyl-aGS-393GS-0393
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell differentiation stimulantsHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsHepatitis, ChronicHepatitisCarcinoma, Hepatocellular +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[13] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesRega Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTongji UniversityNovartis Pharma AgPharmasset Ltd +[6] 
Active IndicationsN/A
Inactive IndicationsHepatitis, ChronicHepatitisCarcinoma, Hepatocellular +[6] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG